Philip M. Kluin

11.8k citations

130 papers · 6.8k indexed · 2 hit papers · h-index 47

Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 73
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 32
Oncology top 1%
- Viral-associated cancers and disorders 25
Immunology top 1%
- Immune Cell Function and Interaction 14
- Immunotherapy and Immune Responses 9
Hematology top 1%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 9
Neurology
- CNS Lymphoma Diagnosis and Treatment 8
Dermatology
- Cutaneous lymphoproliferative disorders research 8

Co-authors: Ed Schuuring Hanneke C. Kluin‐Nelemans Paul P. Tak Tom Smeets A. Edo Meinders Mohamed R. Daha Gustaaf W. van Imhoff Ferdinand C. Breedveld
Cited by: Pathology and Forensic Medicine Genetics Oncology
Journals: New England Journal of Medicine (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Philip M. Kluin

129 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Philip M. Kluin

Since Specialization

Citations

This map shows the geographic impact of Philip M. Kluin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Kluin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Kluin more than expected).

Fields of papers citing papers by Philip M. Kluin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip M. Kluin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Kluin. The network helps show where Philip M. Kluin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip M. Kluin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip M. Kluin Line = papers co-authored together Philip M. Kluin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Case report of a clinically indolent but morphologically high‐grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma? Journal of Cutaneous Pathology ·Claire L. W. Wardle,J Oldhoff,Arjan Diepstra,Peter Valent,Hans‐Peter Horny,Hanneke N.G. Oude Elberink,Philip M. Kluin,Gilles F.H. Diercks	2021	2
2	Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study The Journal of Rheumatology ·Rodney Pollard,Justin Pijpe,Hendrika Bootsma,Fred K. L. Spijkervet,Philip M. Kluin,Jan L.N. Roodenburg,Cees G. M. Kallenberg,Arjan Vissink,Gustaaf W. van Imhoff	2011	51
3	Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer Clinical Cancer Research ·Johan H. Gibcus,Lorian Menkema,Mirjam F. Mastik,Mario Hermsen,Geertruida H. de Bock,Marie‐Louise F. van Velthuysen,Robert P. Takes,Klaas Kok,César Marcos,Bernard F. A. M. van der Laan,Michiel W. M. van den Brekel,Johannes A. Langendijk,Philip M. Kluin,Jacqueline E. van der Wal,Ed Schuuring	2007	74
4	Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma Journal of Clinical Oncology ·Annuska M. Glas,Laurent Knoops,Leonie Delahaye,Marie José Kersten,Robby E. Kibbelaar,Lodewyk A. Wessels,Ryan K. van Laar,J. Han van Krieken,Joke W. Baars,John Raemaekers,Philip M. Kluin,Laura van ‘t Veer,Daphne de Jong	2007	197
5	Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma Clinical Cancer Research ·Marije Booman,Jenny Douwes,Annuska M. Glas,Sietske A. Riemersma,Ekaterina S. Jordanova,Klaas Kok,Andreas Rosenwald,Daphne de Jong,Ed Schuuring,Philip M. Kluin	2006	53
6	High numbers of tumour‐infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis The Journal of Pathology ·Sietske A. Riemersma,Joost J. Oudejans,Marcel J. Vonk,Enno Dreef,Frans A. Prins,Patty M. Jansen,Maarten H. Vermeer,P Blok,Robbie E Kibbelaar,Jettie J.F. Muris,Ed Schuuring,Philip M. Kluin	2005	48
7	Early onset post‐transplant lymphoproliferative disease is associated with allograft localization Clinical Transplantation ·Nicolaas A. Bakker,Gustaaf W. van Imhoff,Erik A.M. Verschuuren,Willem J. van Son,Jaap J. Homan van der Heide,Nic J.G.M. Veeger,Philip M. Kluin,Hanneke C. Kluin‐Nelemans	2005	63
8	BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B Genes Chromosomes and Cancer ·Anneke Bosga-Bouwer,Eugenia Haralambieva,Marije Booman,Ronald Boonstra,Anke van den Berg,Ed Schuuring,Eva van den Berg,Philip M. Kluin,Sibrand Poppema	2005	19
9	HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical Transplantation ·Nicolaas A. Bakker,Gustaaf W. van Imhoff,Erik A.M. Verschuuren,Willem J. van Son,Jaap J. Homan van der Heide,Simon P. M. Lems,Nic J.G.M. Veeger,Philip M. Kluin,Hanneke C. Kluin‐Nelemans,Bouke G. Hepkema	2005	31
10	Identification of a novel RAS GTPase‐activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia Genes Chromosomes and Cancer ·Anne R. M. von Bergh,Pauline M. Wijers,Arjan J. Groot,Shama van Zelderen‐Bhola,J.H. Frederik Falkenburg,Philip M. Kluin,Ed Schuuring	2004	20
11	Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies The Hematology Journal ·Martina Wilke,Harry Dolstra,Frans Maas,Jos Pool,Rolf E. Brouwer,JH Falkenburg,A. Rebello,Femke Lamers,Ed Schuuring,Philip M. Kluin,Francis Brasseur,Els Goulmy	2003	32
12	SUCCESSFUL OUTCOME WITH A ???QUINTUPLE APPROACH??? OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER Transplantation ·C. G. Schaar,J.W. van der Pijl,Bart van Hoek,Johan W. de Fijter,Roeland A. Veenendaal,Philip M. Kluin,J. Han van Krieken,Annemarie Hekman,Wim Terpstra,Roel Willemze,Hanneke C. Kluin‐Nelemans	2001	30
13	Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood ·Johannes W.G. Janssen,Jan Willem Vaandrager,Tanja Heuser,Anna Jauch,Philip M. Kluin,Erik Geelen,P. Leif Bergsagel,W. Michael Kuehl,Hans G. Drexler,Takemi Otsuki,Claus R. Bartram,Ed Schuuring	2000	94
14	Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules European Journal of Immunology ·A. Mieke Mommaas,Aat A. Mulder,Reina Jordens,Coby Out,Min Tan,Peter Cresswell,Philip M. Kluin,Frits Koning	1999	41
15	Characterization of the EMS1 Gene and its Product, Human Cortactin Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication ·Ed Schuuring,Henk van Damme,Ellen Schuuring-Scholtes,Els Verhoeven,Rob Michalides,Erik Geelen,Carla de Boer,Herbert Brok,Vera Van Buuren,Philip M. Kluin	1998	34
16	INCREASED EXPRESSION OF IL-15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITHYERSINIA-INDUCED ARTHRITIS AND OSTEOARTHRITIS The Journal of Pathology ·Erik W. Thurkow,Ineke M. van der Heijden,Ferdinand C. Breedveld,Tom Smeets,Mohamed R. Daha,Philip M. Kluin,A. Edo Meinders,Paul P. Tak	1997	95
17	Expression of the Activation Antigen CD27 in Rheumatoid Arthritis Clinical Immunology and Immunopathology ·Paul P. Tak,Rogier Q. Hintzen,Jaap J.M. Teunissen,Tom Smeets,Mohamed R. Daha,René A. W. van Lier,Philip M. Kluin,A. Edo Meinders,Anton J.G. Swaak,Ferdinand C. Breedveld	1996	53
18	Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies Genes Chromosomes and Cancer ·R.E. Kibbelaar,Jan‐Willem R. Mulder,Enno Dreef,Philip M. Kluin,H van Kamp,Hans L. Haak,Anton K. Raap,Hans W. Wessels,Geoffrey C. Beverstock	1992	12
19	Clinical course and pathologic features of conjunctival non-Hodgkin's lymphoma Graefe s Archive for Clinical and Experimental Ophthalmology ·Hussein A. Khalil,Rob JW de Keizer,Philip M. Kluin,Hanneke C. Kluin‐Nelemans,D. de Wolff–Rouendaal	1990	6
20	Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults British Journal of Haematology ·Mariet M. de Planque,Hanneke C. Kluin‐Nelemans,J. Han van Krieken,Philip M. Kluin,Anneke Brand,Geoffrey C. Beverstock,Roel Willemze,Jon J. van Rood	1988	109

About Philip M. Kluin

Philip M. Kluin is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 130 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (73 papers), Chronic Lymphocytic Leukemia Research (32 papers), Viral-associated cancers and disorders (25 papers), Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Genetics (1.5k citations) and Oncology (2.3k citations). Philip M. Kluin has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ed Schuuring, Hanneke C. Kluin‐Nelemans, Paul P. Tak, Tom Smeets, A. Edo Meinders, Mohamed R. Daha, Gustaaf W. van Imhoff, Ferdinand C. Breedveld, Evert-Jan G. Boerma and Ed Schuuring. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact